Alpha 2.0
Login Register
» Authors » M E Van Hoef

M E Van Hoef

Explore the profile of M E Van Hoef including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 144
Followers 0
Related Specialties
General Medicine
Oncology
General Surgery
Top 10 Co-Authors
A Howell
N G Testa
I Baumann
C Lange
E A de Wynter
J P Neijt
M Ranson
A de Graeff
G R Morgenstern
T M Dexter
Published In
Ned Tijdschr Geneeskd
Ann Oncol
Bone Marrow Transplant
Neth J Med
Lancet
Affiliations
Soon will be listed here.
Recent Articles
1.
The unresolved crisis in clinical research can be resolved
Van Hoef M
Lancet Oncol . 2002 Mar; 2(10):595-6. PMID: 11902548
No abstract available.
2.
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)
Champlin R, Schmitz N, Horowitz M, Chapuis B, Chopra R, Cornelissen J, et al.
Blood . 2000 Jun; 95(12):3702-9. PMID: 10845900
Peripheral blood cells are increasingly used in place of bone marrow as a source of hematopoietic stem cells for allogeneic transplantation. The relative efficacy of these 2 approaches is unknown....
3.
Next century's academic clinical research development in blood and marrow transplants requires continental organizational development
Van Hoef M
Bone Marrow Transplant . 2000 Jan; 24(11):1265. PMID: 10642821
No abstract available.
4.
HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT)
Van Hoef M
Bone Marrow Transplant . 1999 Oct; 24(7):707-14. PMID: 10516672
Peripheral blood progenitor cells (PBPC) are being investigated as an alternative stem cell source in allogeneic transplantation. The current paper presents a 'state-of-the-art' review of HLA-identical sibling transplants (PBPCT). Medline...
5.
Haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cell rescue: the effects of the mobilization regimen and post-transplant growth factors
Van Hoef M
Neth J Med . 1998 May; 52(1):30-9. PMID: 9573740
Purpose: Peripheral blood progenitor cells (PBPC), mobilized by chemotherapy, growth factors (GF) or the combination of these modalities are currently used in most autologous transplants settings. Patient selection factors and...
6.
Guidelines for efficient peripheral blood progenitor cell collection
Van Hoef M
Neth J Med . 1996 Jan; 48(1):29-37. PMID: 8775750
In recent years peripheral blood progenitor cells (PBPC) have increasingly been used to support hematological recovery after high-dose chemotherapy treatment. PBPC are collected by leukopheresis after mobilization by chemotherapy and/or...
7.
Timing of peripheral blood progenitor cell (PBPC) collections during recovery from chemotherapy supported by haematopoietic growth factor
Van Hoef M, Baumann I, Lange C, de Wynter E, Testa N, Howell A
Leukemia . 1994 Nov; 8(11):2020-1. PMID: 7967747
No abstract available.
8.
Rapid haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cells (PBPC) as sole source of support collected at a single apheresis
Van Hoef M, Ranson M, Morgenstern G, Baumann I, Lange C, de Wynter E, et al.
Bone Marrow Transplant . 1994 Jun; 13(6):839-40. PMID: 7920325
No abstract available.
9.
Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal...
Van Hoef M, Baumann I, Lange C, Luft T, de Wynter E, Ranson M, et al.
Ann Oncol . 1994 Mar; 5(3):217-24. PMID: 7514434
Background: In advanced breast cancer high-dose consolidation chemotherapy with haematological rescue has resulted in prolonged disease free and overall survival in a small percentage of patients. Maximal reduction of the...
10.
Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC)
Van Hoef M, Radford J, Jones A, Smith I, Earl H, Woll P, et al.
Ann Oncol . 1993 Dec; 4(10):877-81. PMID: 8117608
Background: The hematopoietic growth factor P-100 is a monocyte-colony stimulating factor purified from human urine and has been reported to reduce neutropenia following chemotherapy. In this study the effect and...